Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04650581
Title Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor (FINER)
Acronym FINER
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries NZL | CAN | AUS

Facility Status City State Zip Country Details
Southern Highlands Cancer Centre Bowral New South Wales 2576 Australia Details
Lake Macquarie Private Hospital Gateshead New South Wales 2324 Australia Details
Gosford Hospital Gosford New South Wales 2250 Australia Details
Macquarie University Hospital Macquarie University New South Wales 2109 Australia Details
Shoalhaven Cancer Care Centre Nowra New South Wales 2541 Australia Details
Sunshine Coast University Hospital Birtinya Queensland 4575 Australia Details
Toowoomba Hospital Toowoomba Queensland 4350 Australia Details
Victorian Breast and Oncology Care East Melbourne Victoria 3002 Australia Details
The Northern Hospital Epping Victoria 3076 Australia Details
Frankston Hospital Frankston Victoria 3199 Australia Details
Alfred Hospital Melbourne Victoria 3004 Australia Details
Sunshine Hospital St. Albans Victoria 3021 Australia Details
St John of God Bunbury Bunbury Western Australia 6230 Australia Details
Fiona Stanley Hospital Murdoch Western Australia 6150 Australia Details
Canberra Hospital Garran ACT 2605 Australia Details
Royal Brisbane and Womens Hospital Herston 4029 Australia Details
BCCA - Cancer Centre for the Southern Interior Kelowna British Columbia V1Y 5L3 Canada Details
BCCA - Fraser Valley Cancer Centre Surrey British Columbia V3V 1Z2 Canada Details
BCCA - Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
Regional Health Authority B, Zone 2 Saint John New Brunswick E2L 4L2 Canada Details
QEII Health Sciences Centre Halifax Nova Scotia B3H 1V7 Canada Details
Royal Victoria Regional Health Centre Barrie Ontario L4M 6M2 Canada Details
William Osler Health System Brampton Ontario L6R 3J7 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
Kingston Health Sciences Centre Kingston Ontario K7L 2V7 Canada Details
London Regional Cancer Program London Ontario N6A 5W9 Canada Details
Stronach Regional Health Centre at Southlake Newmarket Ontario L3Y 2P9 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario K1H 8L6 Canada Details
Algoma District Cancer Program Sault Ste. Marie Ontario P6B 0A8 Canada Details
Thunder Bay Regional Health Sciences Centre/ Thunder Bay Ontario P7B 6V4 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
Windsor Regional Cancer Centre Windsor Ontario N8W 2X3 Canada Details
Centre Integre de Sante et de Services Sociaux Greenfield Park Quebec J4V 2H1 Canada Details
CHUM-Centre Hospitalier de l'Universite de Montreal Montreal Quebec H2X 3E4 Canada Details
CHA-Hopital Du St-Sacrement Quebec City Quebec G1S 4L8 Canada Details
Allan Blair Cancer Centre Regina Saskatchewan S4T 7T1 Canada Details
Saskatoon Cancer Centre Saskatoon Saskatchewan S7N 4H4 Canada Details
Auckland City Hospital Auckland 1023 New Zealand Details
Wellington Cancer Centre, Wellington Hospital Wellington 2 New Zealand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field